GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 135 filers reported holding GOSSAMER BIO INC in Q4 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,156,000 | +349.3% | 513,793 | +214.0% | 0.00% | +100.0% |
| Q2 2022 | $1,370,000 | -23.2% | 163,626 | -19.8% | 0.00% | 0.0% |
| Q1 2022 | $1,784,000 | -16.1% | 203,936 | -1.5% | 0.00% | 0.0% |
| Q4 2021 | $2,127,000 | -8.9% | 206,954 | -6.8% | 0.00% | 0.0% |
| Q3 2021 | $2,335,000 | +25.9% | 221,959 | -2.8% | 0.00% | 0.0% |
| Q2 2021 | $1,854,000 | -78.8% | 228,347 | -75.8% | 0.00% | -66.7% |
| Q1 2021 | $8,735,000 | +25.8% | 944,294 | +31.5% | 0.00% | +50.0% |
| Q4 2020 | $6,945,000 | -1.5% | 718,216 | +26.4% | 0.00% | -33.3% |
| Q3 2020 | $7,054,000 | +188.2% | 568,420 | +201.9% | 0.00% | +200.0% |
| Q2 2020 | $2,448,000 | +24.6% | 188,290 | -2.8% | 0.00% | 0.0% |
| Q1 2020 | $1,965,000 | -29.5% | 193,621 | +8.6% | 0.00% | 0.0% |
| Q4 2019 | $2,786,000 | -2.8% | 178,240 | +4.4% | 0.00% | 0.0% |
| Q3 2019 | $2,866,000 | +33.1% | 170,693 | +75.8% | 0.00% | 0.0% |
| Q2 2019 | $2,153,000 | – | 97,069 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 1,513,138 | $19,020,000 | 4.68% |
| Omega Fund Management, LLC | 3,320,608 | $41,740,000 | 4.68% |
| Ally Bridge Group (NY) LLC | 1,175,000 | $14,770,000 | 4.34% |
| Parkman Healthcare Partners LLC | 786,870 | $9,891,000 | 2.50% |
| Palo Alto Investors LP | 1,772,950 | $22,286,000 | 1.34% |
| HHLR ADVISORS, LTD. | 7,420,974 | $93,282,000 | 1.22% |
| Ikarian Capital, LLC | 1,351,933 | $16,995,000 | 1.20% |
| Boxer Capital, LLC | 2,462,358 | $30,952,000 | 1.08% |
| ACUTA CAPITAL PARTNERS, LLC | 215,000 | $2,703,000 | 0.95% |
| EMERALD ADVISERS, LLC | 1,516,003 | $19,056,000 | 0.69% |